Full text
| |
| Author(s): |
Vanderleia Radaelli
Total Authors: 1
|
| Document type: | Master's Dissertation |
| Press: | Campinas, SP. |
| Institution: | Universidade Estadual de Campinas (UNICAMP). Instituto de Geociências |
| Defense date: | 2006-04-28 |
| Examining board members: |
João Eduardo de Moraes Pinto Furtado;
Wilson Suzigan;
Lia Hasenclever
|
| Advisor: | João Eduardo de Moraes Pinto Furtado |
| Abstract | |
The present dissertation handle deals with to the pharmaceutical industry and the structural transformations in its chain of value, that have produced impacts varied between the actors and institutions that integrate it. Centered in the analysis of the technological activities, the work searchs to understand in which situations the decentralization route the developing countries occurs and in which the centralization is strengthened. The conclusion standes out that some consolidated standards and behaviors had been being modified in order to allow that small companies started to integrate articulated strategies of research. In this new picture, it offers and the demand of scientific knowledge joins agents with different attributions and resources. Strategies of outsourcing international show a relative flexibilization in the barriers to the entrance, what it makes possible in some measure, insertion of small companies in specific technological niches. However, the research carried through with great pharmaceutical companies sample that initiatives of decentralization of technological activities still are hesitates and prompt. United States, Europe and Japan withhold together the biggest portion of these selective invest (AU) | |